6Ross R. Atherosclerosis-an inflation disease[ J]. New Engl J Med, 1999, 340(1) :115 - 126.
7Hofbauer L, Schoppet M. Clinical implications of the osteoprotegerin/ RANKL/RANK system for bone and vascular diseases [ J ]. JAMA ,2004, 29(2) :490 -449.
8Scirica BM, Morrow DA,Cannon CP, et al. Clinical application of C-reac- tive protein across the spectrum of acute coronary syndromes [ J ]. Clinical Chemistry ,2007,53 ( 10 ) : 1800 - 1807.
9Jono S, Ikari Y, Shioi A, et al. Serum Osteoprotegerin levels are associat- ed with the Presence and severity of coronary" artery disease[ J]. Circula- tion,2002,10 (6) : 1192 - 1 194.
10Anand DV, Lahiri A, Lira E, et al. The reiationgship between plasma os- teorotegerin levels and coronary artery calcification in uncomplicated type2 diabetic subjects [J]. JACC,2006,47(9):1850-857.
